-
Skechers agrees to settlement after unfounded claims about benefits of their shoes Wednesday, May 16, 2012
Associated Press: The company has agreed to pay $40 million for claims about its shoes endorsed by celebrities such as Kim Kardashian and Brooke Burke.
CONTINUE READING -
What can be done to fight rising health insurance premiums in California? Tuesday, May 1, 2012
California Progress Report: Zack Kaldveer reports on California’s rapidly rising health insurance premium rates and what can be done to slow them.
CONTINUE READING -
Cap on damage awards declared unconstitutional in Mississippi Tuesday, April 24, 2012
Associated Press: A judge declared the statutory cap on non-economic damages unconstitutional because “the rights of a person to a remedy for an injury and to have that decided by a jury include the assessment of damages.”
CONTINUE READING -
MetLife settles accusations it didn’t pay out life insurance benefits Tuesday, April 24, 2012
New York Times: MetLife has agreed to pay $40 million after accusations it didn’t check its database of policyholders against Social Security death records to determine if it needed to send benefit payments to survivors.
CONTINUE READING -
Two automakers agree to settle unintended acceleration cases Wednesday, February 29, 2012
Safety Research & Strategies: It’s not just Toyota that faces allegations of sudden unintended acceleration; Kia and Subaru have both reached confidential settlements regarding similar issues with their vehicles.
CONTINUE READING -
Preliminary approval for Chinese drywall settlement Wednesday, January 11, 2012
Associated Press: A Chinese drywall manufacturer has agreed to pay for repairs of about 4,500 homes ruined by contaminated product in a settlement that would also cover health problems stemming from the drywall.
CONTINUE READING -
Conflicts of interest reported for FDA panel that signed off on Yaz birth control drug Wednesday, January 11, 2012
Washington Monthly blog: An investigation by journalists found some members of a U.S. Food and Drug Administration committee of medical experts that looked into the potential dangers of the Bayer birth control pills Yaz and Yasmin had potential conflicts of interest.
CONTINUE READING